A Study of LY2405319 in Participants With Type 2 Diabetes

NCT01869959 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2405319
DRUG: Placebo

Sponsor

Eli Lilly and Company